Child-resistant packaging is used to reduce the risk of poisoning in children via the ingestion of potentially hazardous items including certain prescription and OTC medications, pesticides, and household chemicals.
CHPA is the home for responsible members of the consumer healthcare community. We represent leading manufacturers, and the companies that service them, in the area of OTC medicines, dietary supplements, and OTC medical devices.
CHPA opposes mandatory manufacturer-funded drug take-back programs as they threaten the affordability of OTC medications that consumers rely on as the first line of defense against common ailments.
The 2024 U.S. Self-Care Marketing Awards recognizes the strategic innovation and marketing expertise of our member companies in over-the-counter (OTC) medicine, dietary supplement, and OTC medical device industries.
Acetaminophen is a safe OTC analgesic that's widely used by adults and children when following recommended dosage guidelines. Lawmakers should oppose restrictions to access for either age group, as drug regulatory entities already actively monitor research and update consumer protections.
Lawmakers should refrain from imposing unnecessary access barriers to diphenhydramine, as leading manufacturers continuously assess and implement efforts to curb teen abuse without limiting adult availability.
Since the Final Rule was published in 1995, FDA has received six Citizen Petitions (CPs) requesting the addition of alternatives to the animal caries test to the Anticaries Monograph.
This Proposed Safety Administrative Order addresses the GRASE status of codeine, codeine phosphate, and codeine sulfate as antitussive active ingredients.
CHPA supports a review of existing rules and coordination efforts to identify opportunities that could mitigate shortage risks during times of peak need.
